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Introduction and background
Th  e central focus of disease surveillance systems is the 
early identiﬁ   cation of infectious disease outbreaks in 
order to rapidly implement eﬀ  ective control measures for 
minimizing disease transmission and morbidity. Today, a 
heightened challenge in understanding these disease 
dynamics is the interconnected nature of our global 
society. Diseases cross international borders and present 
in unique ways through a continuously changing land-
scape. Th   is challenge makes it diﬃ   cult to rapidly identify, 
analyze and respond to disease outbreaks. Appropriate 
and eﬀ   ective monitoring of newly recognized disease 
events requires established, standardized and well-
maintained global surveillance systems with ﬂ  exible 
components for identifying and responding to such 
events under the guiding principles of the World Health 
Organization’s (WHO) International Health Regulations 
(IHR[2005]) [1].
In 1997, the U.S. Department of Defense (DoD) estab-
lished the Global Emerging Infections Surveillance and 
Response System (GEIS) in response to the U.S. 
Presidential Decision Directive NSTC-7, which detailed 
the need for more robust global disease surveillance [2]. 
In 2008, GEIS, as a global system, was integrated into the 
newly formed Armed Forces Health Surveillance Center 
(AFHSC) [3]. Th  e primary mission of AFHSC-GEIS is 
global disease surveillance and assessment of public 
health events aﬀ  ecting U.S. service members and host 
country partners around the world. A large portion of 
this mission is accomplished through the DoD overseas 
research laboratories, which were initially established 
within partner host countries to conduct research on 
infectious diseases of local and regional concern [4]. Th  is 
capacity has subsequently been leveraged by AFHSC-
GEIS for the purpose of disease surveillance and response 
through a growing network of centrally funded partners 
(Figure 1).
Th   ere are currently ﬁ  ve DoD overseas research labora-
tories that serve as primary AFHSC-GEIS partners: the 
Armed Forces Research Institute of Medical Sciences 
(AFRIMS) in Bangkok, Th   ailand; the U.S. Army Medical 
Research Unit – Kenya (USAMRU-K) in Nairobi, Kenya; 
the U.S. Naval Medical Research Center Detachment 
(NMRCD) in Lima, Peru; the U.S. Naval Medical 
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Public HealthResearch Unit No. 2 (NAMRU-2) which conducts sur-
veil  lance in Southeast Asian countries; and the U.S. Naval 
Medical Research Unit No. 3 (NAMRU-3) in Cairo, Egypt. 
Additionally, the AFHSC-GEIS network includes substan-
tial contributions from three U.S.-based research labora-
tories and a major regional medical center in Europe. Th  e 
Naval Health Research Center (NHRC) in San Diego, 
California conducts population-based surveil  lance among 
basic military trainees at eight of the ten major military 
training centers in the U.S., disease sur  veillance among 
shipboard service members in the U.S. naval ﬂ  eets, and 
infectious disease surveillance in six clinics and two 
hospitals along the U.S.-Mexico border (in collaboration 
with the U.S. Centers for Disease Control and Prevention 
[CDC] and the County of San Diego Health Department). 
Th   e U.S. Air Force School of Aerospace Medicine 
(USAFSAM) in San Antonio, Texas (formerly the Air Force 
Institute for Operational Health) serves as the Air Force’s 
clinical reference laboratory and public health center and 
is the lead organization for the U.S. military’s installation-
based inﬂ  uenza sentinel sur  veil  lance program. Th  e  Walter 
Reed Army Institute of Research’s Division of Viral 
Diseases (WRAIR-DVD) in Silver Spring, Maryland serves 
as a central DoD hub for providing full-length genomic 
sequencing capability and conducts surveillance among 
U.S. civilians assigned to Department of State embassies, 
consulates and missions overseas. Additionally, a partner-
ship between the Landstuhl Regional Medical Center 
(LRMC) and the U.S. Army Public Health Command 
Region-Europe (PHRC-Europe) in Landstuhl, Germany 
function as a regional military medical center and 
support surveillance for respira  tory pathogens and other 
emerging infectious diseases (EID) within the U.S. 
European Command, or EUCOM.
Building the core capacities at the local level as 
described in Annex 1 of the IHR(2005) is a primary focus 
and strategic goal of the AFHSC-GEIS network [5]. 
Support for these eﬀ  orts develops the capability for open 
lines of communication between IHR States Parties, but 
takes years of system strengthening and development. 
Th  e interaction and communication between States 
Parties, as deﬁ  ned in Article 44 in the IHR(2005), allow 
for collaborative exchanges and system strengthening, 
and most importantly, build bilateral relationships on a 
ﬁ  rm foundation of trust at the local level. We feel these 
are critical components of the long-standing relationships 
between the AFHSC-GEIS network partners and their 
sponsor host countries and all move the greater global 
health community closer to implementation of the 
IHR(2005).
System components
Surveillance
Laboratory-based surveillance
Beginning in 2006, the DoD’s global disease surveillance 
network has worked to enhance the existing surveillance 
Figure 1. AFHSC-GEIS Global Network of Partners: Global Infl  uenza Surveillance Sites.
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pandemic. Th  e goals of these expansion eﬀ  orts include 
broadening the network to monitor and detect increasing 
numbers of avian (H5N1) inﬂ  uenza outbreaks around the 
world and identifying new infectious disease threats [6]. 
Th  is expansion of capacity and function was both 
appropriate and fortuitous as AFHSC-GEIS network 
partners at NHRC and USAFSAM were the ﬁ  rst in the 
world to identify the novel inﬂ  uenza A/H1N1 strain in 
April 2009 in California and Texas [7,8]. Th  is rapid 
detection and subsequent response during the tail end of 
the inﬂ  uenza season allowed the appearance of this novel 
strain to be identiﬁ  ed and reported as a potential public 
health emergency of international concern (PHEIC) by 
the U.S. IHR National Focal Point to the WHO. With the 
onset of this inﬂ   uenza A/H1N1 pandemic in April of 
2009, there were signiﬁ  cant  eﬀ   orts by AFHSC-GEIS 
network partners to assist the global health community 
in responding to this global threat.
Electronic surveillance
Electronic disease surveillance is also an important com-
po  nent of a comprehensive global public health disease 
prevention and control strategy, and contributes signiﬁ  -
cantly to capacity building and support for IHR(2005) 
implementation in partner countries. Using electronic 
methods for data collection and analysis allows for 
accurate and timely outbreak detection as well as provid-
ing meaningful situational awareness during, or in the 
aftermath of, an outbreak or pandemic. Th  e AFHSC-
GEIS network has supported a number of electronic 
disease surveillance initiatives over the past several years 
in partnership with several DoD overseas laboratories, 
host country health and defense ministries and our 
technical partner, the Johns Hopkins University Applied 
Physics Laboratory (JHU/APL) [9].
AFHSC-GEIS has relied on the extensive experience 
that JHU/APL acquired in the design and implementation 
of the Electronic Syndromic Surveillance for Early 
Notiﬁ   cation of Community-based Epidemics (also 
known as ESSENCE) system [10]. Th   is electronic disease 
surveillance system is used worldwide at all DoD military 
treatment facilities, throughout the entire U.S. Veterans 
Health Administration system, and in at least twelve U.S. 
state health facilities. Tools have been created to enable 
data collection from the most sophisticated sources 
down to remote settings where data have traditionally 
been diﬃ   cult, if not impossible, to collect and analyze. 
Th  ese tools have broad-reaching applicability in any 
resource-limited setting, whether it is overseas or in 
response to a complex emergency in the United States 
[11]. Th   e following describes some of the eﬀ  orts that have 
focused on adapting electronic surveillance techniques to 
resource-limited settings.
Two electronic surveillance eﬀ  orts were developed by 
partners in Southeast Asia and optimized in 2009, includ-
ing a project with the Royal Th   ai Army (RTA) in remote 
border areas as well as a pilot Short Message Service 
(SMS)-based project in the Philippines. Th  is  project  was 
developed by the RTA with support from AFRIMS and 
AFHSC-GEIS, and reports diseases in both military and 
local civilian populations through faxing reports or 
through voice via military radio. Th   e next generation of 
the system was ﬁ   elded recently, and simpliﬁ  ed  data 
collection from 216 symptoms and categorization into 12 
syndromes that are consistent with the Th   ai Ministry of 
Health’s reporting requirements. Th  is updated system 
also added questions about poultry exposure, lepto-
spirosis, novel A/H1N1 infection, and chickungunya virus 
infection. Although no major outbreaks of disease were 
detected by this system in 2009, it continued to provide 
situational awareness for the RTA and Th  ai Ministry of 
Health [9].
Infrastructure development
Capacity building initiatives continue to be a major focus 
area for the AFHSC-GEIS contributions to worldwide 
EID surveillance and response activities. Surveillance, 
response, laboratory capacity and human resource 
develop  ment are listed as four of the main core capacities 
within the IHR(2005). With regards to laboratory 
capacity, it has been suggested in developing countries 
this function may be the “Achilles’ Heel” of global eﬀ  orts 
to combat infectious diseases [12]. As a result of this, 
many of the AFHSC-GEIS sponsored activities in 
capacity building have been directed at improving the 
existing infrastructure through renovation of existing 
laboratory facilities, furnishing of new scientiﬁ  c equip-
ment, and provision of new or enhanced diagnostic 
testing systems for overseas host country laboratories. In 
2009 alone, eﬀ  orts were coordinated with over 80 local 
and regional health, agriculture and defense ministries, 
as well as other governmental oﬃ   cials and institutions in 
74 countries worldwide. During the same time period, a 
total of 52 National Inﬂ  uenza Centers (NICs) and other 
country-speciﬁ  c  inﬂ   uenza and other EID reference 
laboratories (44 civilian, 8 military) were supported in 46 
countries [9]. Partner countries in all major regions of the 
world were supported but special emphasis was placed 
on capacity building eﬀ  orts in Sub-Saharan (East, Central 
and West) Africa, with activities taking place in fourteen 
diﬀ   erent countries in-line with stated global health 
priorities and areas of enhanced focus for such eﬀ  orts 
[13,14].
Th  is past year, AFHSC-GEIS established two new 
biosafety level 3 (BSL-3) laboratory suites within DoD 
partner countries. Th  e  ﬁ  rst suite was established by the 
AFRIMS in Bangkok, Th   ailand and was U.S.-certiﬁ  ed and 
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inaugurated in September of 2009 and began immediately 
supporting work in avian and pandemic inﬂ  uenza 
monitoring, including culture and molecular sequencing 
capability. Th  is BSL-3 laboratory constitutes the ﬁ  rst 
certiﬁ  ed laboratory of its kind in the region and provides 
the host country and other countries in Southeast Asia 
with a much-needed high containment capability to 
conduct research and assist with outbreaks involving 
select human and animal bacterial and viral strains. A 
second BSL-3 laboratory suite was opened in late 2009 in 
San Diego, California by partners at NHRC, allowing 
work with zoonotic inﬂ   uenza strains submitted by 
AFHSC-GEIS partners throughout the world, to include 
development of new virus testing capabilities against 
H5N1 and other highly pathogenic avian inﬂ  uenza 
strains. Additionally, two BSL-2 laboratories were estab-
lished in Cameroon, including the Cameroon Army 
Military Health Research Center in Yaoundé and at the 
University of Buea in Western Cameroon (Figure 2). Both 
laboratories will help to improve the ability to conduct 
inﬂ  uenza and EID diagnostic work in the country [5].
Developing and deploying inﬂ  uenza diagnostic capa-
bili  ties through other NICs were also supported by the 
NAMRU-3 in Afghanistan, Jordan, and Iraq; by the U.S. 
NMRCD-Peru in Venezuela, Colombia, Paraguay, and 
Ecuador; and, in Kenya by the USAMRU-Kenya. Finally, 
in collaboration with the CDC’s Central America and 
Panama Center, the U.S. Army Public Health Command 
Region–South (PHCR-South) provided laboratory tech-
nical assistance, reagents and supplies to the health 
ministries in El Salvador, Guatemala, Honduras, Nicaragua, 
and Panama, resulting in the certiﬁ  cation of the Guate-
malan NIC and in the testing of over 5,000 specimens for 
novel A/H1N1 [5].
Outbreak support
Rapid identiﬁ  cation of outbreaks and support of timely 
response eﬀ  orts are key components of complying with 
IHR(2005), and are core focus areas of the AFHSC-GEIS 
network [5,15]. Th  ese  eﬀ  orts are provided in response to 
host country requests for assistance with new or ongoing 
outbreaks and consists of a wide range of functional 
support. Th   ese support eﬀ  orts include ﬁ  eld team support, 
epidemiology or consultative support and/or laboratory 
diagnostic support. Th  ese  collaborative  exchanges 
strengthen relationships, build and maintain trust and 
are a critical component of the long-standing relation-
ships built between the network partners and their 
sponsor host countries. Several of the partnerships 
between the U.S. and host country militaries (mil-mil 
partnerships) that have developed over many years have 
served to empower the host country military’s role in 
supporting outbreak response activities within their own 
countries and ultimately support the guiding principles 
of surveillance and response core capacities within the 
IHR(2005) [16].
Over the past full year of surveillance (September 
2008-October 2009), the AFHSC-GEIS network respon-
ded to 76 outbreaks in 53 countries, several in direct 
support of the IHR(2005). Th  e most common events 
investigated were inﬂ  uenza (47), cholera (4), dengue fever 
(4) and hepatitis (3). Human disease was detected in all but 
one of these outbreaks and speciﬁ  c causative agents were 
identiﬁ   ed in 92%, or 69, of them. Th  e population size 
aﬀ  ected ranged from less than 10 individuals to several 
thousand and support eﬀ  orts were often ongoing engage-
ments beyond the initial phase of the investigation [15].
Beginning in April of 2009, with the onset of the 
inﬂ  uenza pandemic, disease surveillance and investiga  tive 
response activities were dominated by novel inﬂ  uenza A/
H1N1. Th  e AFHSC-GEIS network supported the diag-
nostic conﬁ   rmation (directly in DoD laboratories or 
through support of host country laboratories) of the ﬁ  rst 
inﬂ  uenza A/H1N1 cases in fourteen countries (United 
States, Bhutan, Cambodia, Djibouti, Kuwait, Kenya, Lao 
People’s Democratic Republic, Lebanon, Egypt, Nepal, 
Colombia, Ecuador, Peru and the Republic of the 
Seychelles), again demonstrating direct support for 
increas  ing compliance with IHR(2005) for what was 
deemed at the time as a PHEIC. Th  e non-U.S. activities 
were a result of the respective AFHSC-GEIS partner 
laboratory’s role as the regional reference testing center 
and the bilateral working collaborations with host country 
health ministries and partner governments. Th  ese  bilateral 
relationships resulted in response to seventeen large-scale 
outbreaks among civilians in thirteen countries [15].
United States service members and beneﬁ  ciaries were 
aﬀ  ected by novel H1N1 in all regions of the world within 
the ﬁ  rst month of the outbreak. In the ﬁ  rst wave of the 
pandemic (April through August 2009), the AFHSC-GEIS 
Figure 2. Newly Commissioned Biosafety Level-2 Laboratory at 
the University of Buea, Cameroon.
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outbreaks on U.S. military installations and among 
deﬁ   ned high-risk groups [17]. Th  ese high-risk groups 
were deﬁ   ned as deployed or deploying personnel, 
shipboard personnel, new accessions (basic and advanced 
military trainees and service academy students), health 
care workers, children and staﬀ   in daycare centers and 
pregnant women. Stressful military environments, highly-
mobile missions and complex troop dynamics have 
proven in the past to help to propagate pandemics and 
have drawn the attention of the military’s operational 
leadership and leaders of civilian sectors within host 
countries [18]. Th  ese investigations involved anywhere 
from a few dozen cases to situations where greater than 
one thousand cases were tested at a given time.
Training
In order to achieve optimal and coordinated implemen  ta-
tion of the IHR(2005), it is required that each State Party 
be capable of detecting, conﬁ   rming, reporting, and 
containing an emerging threat to public health [1] and 
build these capabilities by 2012. To reach the 2012 
milestones, States Parties will need to signiﬁ  cantly 
enhance their laboratory infrastructure and more impor-
tantly, appropriately train the personnel who can perform 
the core capacity functions as deﬁ  ned by Article 5 of 
IHR(2005). Th  ese core capacities include leading out-
break investigations, correctly identifying a pathogen in 
the laboratory, rapidly communicating the ﬁ  ndings  to 
stakeholders at all levels and, most importantly, control-
ling the outbreak through tested, coordinated and 
exercised mitigation eﬀ   orts. Frontline public health 
professionals require the latest knowledge and skills to 
address global threats to public health.
Th  e recent pandemic of novel inﬂ  uenza  A/H1N1 
clearly illustrates the unpredictable nature of pathogens 
which require dynamic and evolving public health 
strategies for surveillance, disease management, and 
eﬀ  ec  tive mitigation. Training public health professionals 
to understand, monitor, respond to, control, and prevent 
emerging infections is a foundational goal of AFHSC-
GEIS [19]. Since its inception, AFHSC-GEIS partners and 
collaborators have made available their overseas labora-
tory and ﬁ  eld study facilities to serve as regional focal 
points for public health training of staﬀ  , technicians and 
epidemiologists within partner host countries [2,6,20] 
through a growing collaborative network of U.S. Govern-
ment agency partners (Figure 3). A wide range of training 
has been coordinated to include programs such as the 
CDC’s Field Epidemiology Training and Laboratory 
Training Programs [21] and the U.S. Agency for Inter-
national Development (USAID) eﬀ  orts throughout Africa 
and the Paciﬁ  c [22,23,24]. Th  ese opportunities through 
training serve as a forum for support, coordination, and 
collaboration with host country partners as prescribed in 
Article 44 of the IHR(2005).
A regional approach to training has been underway by 
the Uniformed Services University of the Health Sciences 
(USUHS) Center for Disaster and Humanitarian Assis-
tance Medicine (CDHAM). Educational eﬀ  orts in support 
of ﬁ  ve combatant commands have been bolstered with 
AFHSC-GEIS funding and provide much-needed profes-
sional expertise and the latest technical informa  tion to 
U.S. military and civilian health care providers as well as 
to host country of health, agriculture, defense ministries 
and other civilian agency collaborators. Th  ese  initiatives 
result in professional engagement for host country 
oﬃ   cials as well as further enhancing the U.S. govern-
ment’s role as a key stakeholder in the global health 
community. Training initiatives are broadly based to en-
com  pass such topics as planning and preparedness, 
outbreak investigation, surveillance and response and 
Figure 3. Two week Makarere University, Uganda training for thirty six laboratory scientists from throughout Sub-Saharan Africa.
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syndrome causing agents [19].
Over the past full year of partner funding, 18 diﬀ  erent 
organizations conducted 123 training initiatives in 40 
countries reaching approximately 3,130 U.S. military and 
civilian personnel as well as host country personnel. Th  e 
most common categories covered were EID laboratory 
techniques (41%), pandemic inﬂ  uenza (24%), and disease 
surveillance techniques (19%). Training tools included 
work shops  (deﬁ  ned here as hands-on, interactive train-
ing), academic courses, conferences, tabletop exercises, 
and distance learning. Training duration ranged from 
0.5 hours to 6 months, with the majority of education 
eﬀ  orts lasting 2 to 5 days. Respiratory infections (namely 
inﬂ  u  enza) represented the majority of training initiatives 
(68%), followed by febrile and vector-borne infections 
(11%), gastrointestinal infections (5%), and antimicrobial 
resistance (2%) with an additional 14% represented by 
various other topics (Geographic Information Systems, 
EpiInfo, Field Epidemiology, Principles and Practice of 
Clinical Research, Outbreak Investigation, Emerging 
Infectious Diseases, Lab Safety Precautions, Ecological 
Niche Modeling, and Tropical Medicine Student Rotations). 
Training initiatives occurred in each of the six regional 
Combatant Commands with most occurring in the 
Paciﬁ  c Command, or PACOM [19].
Communication tools
Communication and central coordination remains a 
primary role of AFHSC and involves a substantial 
amount of eﬀ  ort from all divisions and areas, including 
GEIS. In a given month during the Northern Hemisphere 
respiratory season, the AFHSC creates, on average, 139 
individual reports for a wide spectrum of disease-causing 
agents or matters of public health concern. Th  is  includes 
routine reportable medical event reports that are noted 
in the Medical Surveillance Monthly Reports [25]. Many 
of the reports generated by AFHSC are available on the 
program website and are open to access by the general 
public. Other reports are provided to the individual 
services and are usually part of speciﬁ   c data request 
agreement with that service.
Respiratory surveillance, and more speciﬁ  cally  inﬂ  u-
enza surveillance, remains the primary area of funding 
and focus for many of the global network partners. Th  e 
central coordination and analysis of aggregated inﬂ  uenza 
surveillance data and summarizing of all partner reports 
is a function unique to AFHSC central headquarters. 
AFHSC-GEIS partners are highly encouraged to create 
program-speciﬁ   c reports that are accurate, timely, 
concise, openly available, and provide meaningful public 
health interpretation of the ﬁ  ndings. AFHSC-GEIS staﬀ   
analyze and summarize all partner reports weekly and 
provide a DoD-wide summary to stakeholders across the 
network through the AFHSC website [26]. In addition to 
timely reporting, partners are required to participate and 
communicate their recent ﬁ  ndings through network calls 
and a bi-monthly teleconference called Epi Chiefs. Th  is 
provides a forum for reporting the latest outbreak activity 
and interesting ﬁ  ndings from all regions of the global 
network. It also allows program management staﬀ    to 
communicate outward of notable changes in trends in 
speciﬁ  c regions or areas of concern.
Conclusions
Th   e Armed Forces Health Surveillance Center’s Division 
of Global Emerging Infections Surveillance and Response 
network continues to expand internationally to eﬀ  ectively 
identify and respond to threats from a wide range of 
disease agents and syndromes. Th   e growth and 
enhancement of this surveillance system in anticipation 
of pandemic/avian inﬂ  uenza allowed the DoD to identify 
the recent inﬂ  uenza pandemic [21,22] and a number of 
other infectious disease outbreaks in communities 
around the world. A global system with deﬁ  ned goals and 
pillars of focus, the AFHSC-GEIS network has evolved to 
become a model for emerging infectious surveillance 
platforms at the local, regional and international level. By 
utilizing this established global system and the IHR(2005) 
as a guide, the DoD is able to provide a common and 
systematic approach to disease surveillance, human 
capacity building and a framework for eﬀ  ective public 
health response. As emerging and re-emerging threats 
develop in areas where partners work with host country 
collaborators and global health institutions, the AFHSC-
GEIS network stands ready to respond and support.
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